Which two countries have emerged as the fastest-growing export destinations for Indian pharmaceutical products in April–November 2025-26?

India’s pharmaceutical exports grew by 6.5% in the first eight months of FY 2025-26.

Total pharma exports reached $20.48 billion during April–November 2025-26.

Brazil and Nigeria have emerged as important new markets for Indian pharma products.

Nigeria contributed about $179 million to India’s pharma export growth.

Brazil’s imports from India increased by nearly $100 million due to rising healthcare demand.

India’s pharmaceutical exports benefit from strong demand for affordable generics globally.

The United States remains India’s largest pharma export destination, accounting for over 31% of total exports.

Other stable export markets include France, Netherlands, Canada, Germany, and South Africa.

India is one of the largest global suppliers of generic medicines, exporting to over 200 countries.

Indian pharmaceutical exports contribute significantly to global healthcare by supplying affordable drugs and vaccines.

Historical key export destinations include US, UK, Brazil, France, and South Africa.

The growth highlights the resilience and expanding global footprint of the Indian pharma industry.